Trials / Completed
CompletedNCT00818597
Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients
PhaseI/II Study of the Safety and Efficacy of the Use of Granulocyte-Concentrates Applied in Extracorporeal Circulation Devices-the EISS-1 Study
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Rostock · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of an extracorporeal application of a bed-side bioreactor containing human donor granulocytes on the course and outcome of septic shock in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EISS | Two six hour-treatments with the EISS-Immune-cell bioreactor device within 72 hours post inclusion. |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2004-04-01
- Completion
- 2008-06-01
- First posted
- 2009-01-07
- Last updated
- 2009-01-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00818597. Inclusion in this directory is not an endorsement.